JP Morgan Maintains Overweight on Insulet, Raises Price Target to $225
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Robbie Marcus has maintained an Overweight rating on Insulet (NASDAQ:PODD) and increased the price target from $190 to $225.
February 23, 2024 | 8:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst Robbie Marcus has reaffirmed an Overweight rating on Insulet and raised the price target from $190 to $225.
The increase in price target by a reputable analyst like Robbie Marcus from JP Morgan is a strong positive signal for Insulet. It suggests confidence in the company's future performance and growth prospects, likely leading to increased investor interest and potentially a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100